SMH vs VLXVX: 9% overlap
VanEck Semiconductor ETF and Vanguard Target Retirement 2065 share 8.8% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 3 months apart — SMH, VLXVX as of 2026-03-31, the rest through 2026-06-30. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.9. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
SMH and VLXVX hold 20 of the same securities. The ten contributing most to the overlap figure:
| Holding | in SMH | in VLXVX | Δ |
|---|---|---|---|
| NVDA | 19.6% | 3.3% | 16.3% |
| AVGO | 7.8% | 1.3% | 6.5% |
| MU | 4.2% | 0.9% | 3.3% |
| AMD | 4.7% | 0.7% | 4.0% |
| AMAT | 4.6% | 0.4% | 4.2% |
| INTC | 4.3% | 0.4% | 3.9% |
| LRCX | 4.6% | 0.4% | 4.2% |
| KLAC | 4.7% | 0.3% | 4.5% |
| TXN | 4.6% | 0.2% | 4.4% |
| MRVL | 2.4% | 0.2% | 2.2% |
Where SMH and VLXVX differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | SMH | VLXVX | Δ |
|---|---|---|---|
| Information Technology | 92.8% | 26.3% | +66.5pp |
| Financials | 0.0% | 14.1% | −14.1pp |
| Industrials | 0.0% | 10.6% | −10.6pp |
| Consumer Discretionary | 0.0% | 7.6% | −7.6pp |
| Health Care | 0.0% | 7.0% | −7.0pp |
| Communication Services | 0.0% | 6.0% | −6.0pp |
| Consumer Staples | 0.0% | 4.1% | −4.1pp |
| Treasuries | 0.0% | 3.3% | −3.3pp |
Δ is SMH minus VLXVX, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
19.8% of SMH by weight, held in no part of VLXVX.
91.2% of VLXVX by weight, held in no part of SMH.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| SMH | VLXVX | |
|---|---|---|
| Top 10 holdings | 72.2% | 19.3% |
| Positions held | 26 | 6 |
| Cost per $10,000 held, per year | $35 | $8 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do SMH and VLXVX overlap?
SMH and VLXVX overlap 8.8% by portfolio weight — largely distinct portfolios. They share 20 holdings. The figure comes from current issuer holdings files (SMH as of 2026-03-31, VLXVX as of 2026-03-31).
How is the overlap between SMH and VLXVX calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If SMH holds a stock at 6% and VLXVX holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both SMH and VLXVX?
That depends on your goals — we state facts, not advice. At 8.8% overlap, each fund still contributes meaningfully distinct exposure.
What does SMH own that VLXVX doesn't?
SMH holds 26 positions and VLXVX holds 6; 6 of SMH's positions don't appear in VLXVX at all, and they are 19.8% of SMH by weight.
You probably hold more than two funds
This page compares SMH and VLXVX. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch SMH vs VLXVX
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, SMH as of 2026-03-31, VLXVX as of 2026-03-31. Weights are fractions of each fund. Diagnostics, not advice.